HomeOwner SearchCategory Search
Visit USCONovel molecular strategies for prevention of graft-versus-host disease by ex vivo tolerance induction
Text Registration
Copyright Title
Novel molecular strategies for prevention of graft-versus-host disease by ex vivo tolerance induction
Status
Published
on 19 Mar 2008
Year of Creation
2006
Copyright Claimant
Matthew John O'Shaughnessy
Registration Number
TX0006621111
on 19 Mar 2008Copyright Summary
The U.S. Copyright record (Registration Number: TX0006621111) dated 19 Mar 2008, pertains to an electronic file (eService) titled "Novel molecular strategies for prevention of graft-versus-host disease by ex vivo tolerance induction" created in 2006. The copyright holder is Matthew John O'Shaughnessy, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Matthew John O'Shaughnessy.
Application Details
Registration Number
TX0006621111
Registration Date
3/19/2008
Year of Creation
2006
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Computer text data
Notes
Rights Note: Rights and permissions info. on CORDS appl. in CO
Local Copyright Note: Electronic registration
Statements
Author Statement: entire text: Matthew John O'Shaughnessy
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.